Prelude Therapeutics Incorporat

Q2 2022 13F Holders

Symbol
PRLD
CUSIP
74065P101
Type
Equity
Class
COM
Num filings
65
Total reported value, excl. options
$171 M
Manager Report Date Value ($000) Shares Option Type